C2i Genomics - Crunchbase Company Profile & Funding

Q: Who invested in C2i Genomics?

C2i Genomics has 12 investors including iGlobe Partners And Duquesne Family Office.

Q: When was the last funding round for C2i Genomics?

C2i Genomics closed its last funding round on obfuscated from a Series B round.

Q: How much funding has C2i Genomics raised to date?

C2i Genomics has raised obfuscated.

Overview

C2i Genomics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About C2i Genomics

CB Rank

49525

C2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations.

Acquired by

Veracyte

Founded

obfuscation

Private

Series B

New York, New York, United States

51-100

c2i-genomics.com

Genetics

Health Care

Health Diagnostics

Therapeutics

Funding Rounds

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Alex Parker: Board of Directors
Past Role: Foundation Medicine, Vice President, Business Development
Ezra Sofer: Co-Founder, CEO
Past Role: SunGard, CFO SunGard Trading Systems

Details

Legal Name

C2i Genomics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Asaf Zviran, Boris Oklander, Dan Landau, Ezra Sofer

About the Company

C2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations.

Contact Email

info@c2i-genomics.com

Predictions & Insights

Growth Insight

See this Growth Insight

C2i Genomics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

C2-Intelligence Platform

A cloud-based platform that uses whole-genome sequencing and AI to detect minimal residual disease (MRD) in cancer patients, providing insights for treatment decisions.

Low-input Liquid Biopsy

A blood test requiring only 2-3ml of blood to detect cancer-specific DNA signatures for monitoring tumor burden and treatment response.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - C2i Genomics	11	obfuscated obfuscation	Casdin Capital	Series B
obfuscated obfuscation	Series B - C2i Genomics	11	obfuscated obfuscation	Casdin Capital	Series B
obfuscated obfuscation	Series B - C2i Genomics	11	obfuscated obfuscation	Casdin Capital	Series B
obfuscated obfuscation	Series B - C2i Genomics	11	obfuscated obfuscation	Casdin Capital	Series B
obfuscated obfuscation	Series B - C2i Genomics	11	obfuscated obfuscation	Casdin Capital	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - C2i Genomics	11	obfuscated obfuscation	Casdin Capital	Series B
obfuscated obfuscation	Series B - C2i Genomics	11	obfuscated obfuscation	Casdin Capital	Series B
obfuscated obfuscation	Series B - C2i Genomics	11	obfuscated obfuscation	Casdin Capital	Series B
obfuscated obfuscation	Series B - C2i Genomics	11	obfuscated obfuscation	Casdin Capital	Series B
obfuscated obfuscation	Series B - C2i Genomics	11	obfuscated obfuscation	Casdin Capital	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
iGlobe Partners	—	Series B - C2i Genomics	—
iGlobe Partners	—	Series B - C2i Genomics	—
iGlobe Partners	—	Series B - C2i Genomics	—
iGlobe Partners	—	Series B - C2i Genomics	—
iGlobe Partners	—	Series B - C2i Genomics	—